Celltrion Keeps Pace With Ustekinumab Rivals

Moves CT-P43 Stelara Biosimilar Into Phase III Trials

 
• By David Wallace
  
Running Race Feet
Multiple players are in the race to develop a Stelara biosimilar • Source: Shutterstock

More from Biosimilars

More from Products